ease that are not purely
historical are forward-looking statements within the meaning of Section 27A
of the Securities Act of 1933, as amended and Section 21E of the Securities
Exchange Act of 1934, as amended, and are intended to be covered by the
safe harbors created thereby. These forward-looking statements include, but
are not limited to, statements regarding the expected benefits of the
Company's investment in infrastructure and new customer contract signings
and awards in 2008 and/or statements preceded by, followed by or that
include the words "believes," "could," "expects," "anticipates,"
"estimates," "intends," "plans," "projects," "seeks," or similar
expressions. Forward-looking statements deal with the Company's current
plans, intentions, beliefs and expectations. Investors are cautioned that
all forward-looking statements involve risks and uncertainties that could
cause actual results to differ materially from those in the forward-looking
statements. Many of these risks and uncertainties are discussed in the
Company's Annual Report on Form 10-KSB for the fiscal year ended December
31, 2007 filed with the Securities and Exchange Commission (the "SEC"), and
in any subsequent reports filed with the SEC, all of which are available at
the SEC's website at
http://www.sec.gov. These include without limitation: the
risk of cancellation or delay of customer contracts or specifically as it
relates to contact awards, the risk that they may not get signed. Other
risks include the company's dependence on its largest customers and risks
of contract performance, protection of our intellectual property and the
risks of infringement of the intellectual property rights of others. All
forward-looking statements speak only as of the date of this press release
and the Company undertakes no obligation to update such forward-looking
statements.
CONTACT: Company Contact:
Molly Henderson
'/>"/>
SOURCE VirtualScopics, Inc. Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 Related medicine news :1.
VirtualScopics Schedules Third Quarter 2008 Earnings Announcement2.
VirtualScopics Reports Second Quarter 2008 Results3.
VirtualScopics Receives NASDAQ Delisting Notice; Company Files Appeal to Stay Delisting4.
VirtualScopics Backlog Exceeds a Record $20 Million5.
VirtualScopics Announces $4.35 Million Private Placement6.
Tibotec presents interim findings for TMC435, an investigational genotype 1 hepatitis C treatment7.
BioCryst to Present at the Rodman and Renshaw 10th Annual Healthcare Conference8.
LCA-Vision to Present at the Rodman & Renshaw 10th Annual Healthcare Conference9.
NMB's Fans and Blowers to be Represented in Canada by CST-Arwin10.
The Ensign Group to Present at the Oppenheimer 19th Annual Healthcare Conference11.
Satellite Healthcare Will Present at the American Society of Nephrology's Renal Week – Booth 527 : November 4-9, 2008